Literature DB >> 30567752

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.

Rabea Wagener1,2, Julian Seufert3,4, Francesco Raimondi5, Susanne Bens1,2, Kortine Kleinheinz6,7, Inga Nagel2,8, Janine Altmüller9, Holger Thiele10, Daniel Hübschmann7,11, Christian W Kohler12, Peter Nürnberg9, Rex Au-Yeung13, Birgit Burkhardt14, Heike Horn15, Lorenzo Leoncini16, Elaine S Jaffe17, German Ott15, Grzegorz Rymkiewicz18, Matthias Schlesner3, Robert B Russell5, Wolfram Klapper13, Reiner Siebert1,2.   

Abstract

The new recently described provisional lymphoma category Burkitt-like lymphoma with 11q aberration comprises cases similar to Burkitt lymphoma (BL) on morphological, immunophenotypic and gene-expression levels but lacking the IG-MYC translocation. They are characterized by a peculiar imbalance pattern on chromosome 11, but the landscape of mutations is not yet described. Thus, we investigated 15 MYC-negative Burkitt-like lymphoma with 11q aberration (mnBLL,11q,) cases by copy-number analysis and whole-exome sequencing. We refined the regions of 11q imbalance and identified the INO80 complex-associated gene NFRKB as a positional candidate in 11q24.3. Next to recurrent gains in 12q13.11-q24.32 and 7q34-qter as well as losses in 13q32.3-q34, we identified 47 genes recurrently affected by protein-changing mutations (each ≥3 of 15 cases). Strikingly, we did not detect recurrent mutations in genes of the ID3-TCF3 axis or the SWI/SNF complex that are frequently altered in BL, or in genes frequently mutated in germinal center-derived B-cell lymphomas like KMT2D or CREBBP An exception is GNA13, which was mutated in 7 of 15 cases. We conclude that the genomic landscape of mnBLL,11q, differs from that of BL both at the chromosomal and mutational levels. Our findings implicate that mnBLL,11q, is a lymphoma category distinct from BL at the molecular level.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30567752      PMCID: PMC6396176          DOI: 10.1182/blood-2018-07-864025

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Partial trisomy 11, dup(11)(q23q13), as a defect characterizing lymphomas with Burkitt pathomorphology without MYC gene rearrangement.

Authors:  Barbara Pienkowska-Grela; Grzegorz Rymkiewicz; Beata Grygalewicz; Renata Woroniecka; Paulina Krawczyk; Katarzyna Czyz-Domanska; Jan Walewski
Journal:  Med Oncol       Date:  2010-07-27       Impact factor: 3.064

2.  A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.

Authors:  Itziar Salaverria; Idoia Martin-Guerrero; Rabea Wagener; Markus Kreuz; Christian W Kohler; Julia Richter; Barbara Pienkowska-Grela; Patrick Adam; Birgit Burkhardt; Alexander Claviez; Christine Damm-Welk; Hans G Drexler; Michael Hummel; Elaine S Jaffe; Ralf Küppers; Christine Lefebvre; Jasmin Lisfeld; Markus Löffler; Roderick A F Macleod; Inga Nagel; Ilske Oschlies; Maciej Rosolowski; Robert B Russell; Grzegorz Rymkiewicz; Detlev Schindler; Matthias Schlesner; René Scholtysik; Carsten Schwaenen; Rainer Spang; Monika Szczepanowski; Lorenz Trümper; Inga Vater; Swen Wessendorf; Wolfram Klapper; Reiner Siebert
Journal:  Blood       Date:  2014-01-07       Impact factor: 22.113

3.  Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing.

Authors:  Julia Richter; Matthias Schlesner; Steve Hoffmann; Markus Kreuz; Ellen Leich; Birgit Burkhardt; Maciej Rosolowski; Ole Ammerpohl; Rabea Wagener; Stephan H Bernhart; Dido Lenze; Monika Szczepanowski; Maren Paulsen; Simone Lipinski; Robert B Russell; Sabine Adam-Klages; Gordana Apic; Alexander Claviez; Dirk Hasenclever; Volker Hovestadt; Nadine Hornig; Jan O Korbel; Dieter Kube; David Langenberger; Chris Lawerenz; Jasmin Lisfeld; Katharina Meyer; Simone Picelli; Jordan Pischimarov; Bernhard Radlwimmer; Tobias Rausch; Marius Rohde; Markus Schilhabel; René Scholtysik; Rainer Spang; Heiko Trautmann; Thorsten Zenz; Arndt Borkhardt; Hans G Drexler; Peter Möller; Roderick A F MacLeod; Christiane Pott; Stefan Schreiber; Lorenz Trümper; Markus Loeffler; Peter F Stadler; Peter Lichter; Roland Eils; Ralf Küppers; Michael Hummel; Wolfram Klapper; Philip Rosenstiel; Andreas Rosenwald; Benedikt Brors; Reiner Siebert
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

4.  Genetic heterogeneity of diffuse large B-cell lymphoma.

Authors:  Jenny Zhang; Vladimir Grubor; Cassandra L Love; Anjishnu Banerjee; Kristy L Richards; Piotr A Mieczkowski; Cherie Dunphy; William Choi; Wing Yan Au; Gopesh Srivastava; Patricia L Lugar; David A Rizzieri; Anand S Lagoo; Leon Bernal-Mizrachi; Karen P Mann; Christopher Flowers; Kikkeri Naresh; Andrew Evens; Leo I Gordon; Magdalena Czader; Javed I Gill; Eric D Hsi; Qingquan Liu; Alice Fan; Katherine Walsh; Dereje Jima; Lisa L Smith; Amy J Johnson; John C Byrd; Micah A Luftig; Ting Ni; Jun Zhu; Amy Chadburn; Shawn Levy; David Dunson; Sandeep S Dave
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-04       Impact factor: 11.205

5.  A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.

Authors:  Grzegorz Rymkiewicz; Beata Grygalewicz; Magdalena Chechlinska; Katarzyna Blachnio; Zbigniew Bystydzienski; Joanna Romejko-Jarosinska; Renata Woroniecka; Michalina Zajdel; Katarzyna Domanska-Czyz; David Martin-Garcia; Ferran Nadeu; Pawel Swoboda; Jolanta Rygier; Barbara Pienkowska-Grela; Jan Konrad Siwicki; Monika Prochorec-Sobieszek; Itziar Salaverria; Reiner Siebert; Jan Walewski
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

6.  miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

Authors:  Michalina Zajdel; Grzegorz Rymkiewicz; Magdalena Chechlinska; Katarzyna Blachnio; Barbara Pienkowska-Grela; Beata Grygalewicz; Krzysztof Goryca; Maria Cieslikowska; Zbigniew Bystydzienski; Pawel Swoboda; Jan Walewski; Jan Konrad Siwicki
Journal:  Tumour Biol       Date:  2015-02-13

7.  Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.

Authors:  Roland Schmitz; Ryan M Young; Michele Ceribelli; Sameer Jhavar; Wenming Xiao; Meili Zhang; George Wright; Arthur L Shaffer; Daniel J Hodson; Eric Buras; Xuelu Liu; John Powell; Yandan Yang; Weihong Xu; Hong Zhao; Holger Kohlhammer; Andreas Rosenwald; Philip Kluin; Hans Konrad Müller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Martin D Ogwang; Steven J Reynolds; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; James R Cook; Dennis D Weisenburger; Wing C Chan; Stefania Pittaluga; Wyndham Wilson; Thomas A Waldmann; Martin Rowe; Sam M Mbulaiteye; Alan B Rickinson; Louis M Staudt
Journal:  Nature       Date:  2012-08-12       Impact factor: 49.962

8.  Distinct modes of regulation of the Uch37 deubiquitinating enzyme in the proteasome and in the Ino80 chromatin-remodeling complex.

Authors:  Tingting Yao; Ling Song; Jingji Jin; Yong Cai; Hidehisa Takahashi; Selene K Swanson; Michael P Washburn; Laurence Florens; Ronald C Conaway; Robert E Cohen; Joan W Conaway
Journal:  Mol Cell       Date:  2008-09-26       Impact factor: 17.970

9.  Loss of signalling via Gα13 in germinal centre B-cell-derived lymphoma.

Authors:  Jagan R Muppidi; Roland Schmitz; Jesse A Green; Wenming Xiao; Adrien B Larsen; Sterling E Braun; Jinping An; Ying Xu; Andreas Rosenwald; German Ott; Randy D Gascoyne; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Rita M Braziel; Raymond R Tubbs; J R Cook; Dennis D Weisenburger; Wing C Chan; Nagarajan Vaidehi; Louis M Staudt; Jason G Cyster
Journal:  Nature       Date:  2014-09-28       Impact factor: 49.962

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962

View more
  14 in total

1.  Distinct molecular profile of IRF4-rearranged large B-cell lymphoma.

Authors:  Joan Enric Ramis-Zaldivar; Blanca Gonzalez-Farré; Olga Balagué; Verónica Celis; Ferran Nadeu; Julia Salmerón-Villalobos; Mara Andrés; Idoia Martin-Guerrero; Marta Garrido-Pontnou; Ayman Gaafar; Mariona Suñol; Carmen Bárcena; Federico Garcia-Bragado; Maitane Andión; Daniel Azorín; Itziar Astigarraga; Maria Sagaseta de Ilurdoz; Constantino Sábado; Soledad Gallego; Jaime Verdú-Amorós; Rafael Fernandez-Delgado; Vanesa Perez; Gustavo Tapia; Anna Mozos; Montserrat Torrent; Palma Solano-Páez; Alfredo Rivas-Delgado; Ivan Dlouhy; Guillem Clot; Anna Enjuanes; Armando López-Guillermo; Pallavi Galera; Matthew J Oberley; Alanna Maguire; Colleen Ramsower; Lisa M Rimsza; Leticia Quintanilla-Martinez; Elaine S Jaffe; Elías Campo; Itziar Salaverria
Journal:  Blood       Date:  2020-01-23       Impact factor: 22.113

2.  The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS.

Authors:  Katrin S Hüttl; Annette M Staiger; Julia Richter; M Michaela Ott; Sabrina Kalmbach; Wolfram Klapper; Anne-Sophie Biesdorf; Lorenz Trümper; Andreas Rosenwald; Marita Ziepert; Heike Horn; German Ott
Journal:  Virchows Arch       Date:  2021-03-02       Impact factor: 4.064

Review 3.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.

Authors:  Rita Alaggio; Catalina Amador; Ioannis Anagnostopoulos; Ayoma D Attygalle; Iguaracyra Barreto de Oliveira Araujo; Emilio Berti; Govind Bhagat; Anita Maria Borges; Daniel Boyer; Mariarita Calaminici; Amy Chadburn; John K C Chan; Wah Cheuk; Wee-Joo Chng; John K Choi; Shih-Sung Chuang; Sarah E Coupland; Magdalena Czader; Sandeep S Dave; Daphne de Jong; Ming-Qing Du; Kojo S Elenitoba-Johnson; Judith Ferry; Julia Geyer; Dita Gratzinger; Joan Guitart; Sumeet Gujral; Marian Harris; Christine J Harrison; Sylvia Hartmann; Andreas Hochhaus; Patty M Jansen; Kennosuke Karube; Werner Kempf; Joseph Khoury; Hiroshi Kimura; Wolfram Klapper; Alexandra E Kovach; Shaji Kumar; Alexander J Lazar; Stefano Lazzi; Lorenzo Leoncini; Nelson Leung; Vasiliki Leventaki; Xiao-Qiu Li; Megan S Lim; Wei-Ping Liu; Abner Louissaint; Andrea Marcogliese; L Jeffrey Medeiros; Michael Michal; Roberto N Miranda; Christina Mitteldorf; Santiago Montes-Moreno; William Morice; Valentina Nardi; Kikkeri N Naresh; Yasodha Natkunam; Siok-Bian Ng; Ilske Oschlies; German Ott; Marie Parrens; Melissa Pulitzer; S Vincent Rajkumar; Andrew C Rawstron; Karen Rech; Andreas Rosenwald; Jonathan Said; Clémentine Sarkozy; Shahin Sayed; Caner Saygin; Anna Schuh; William Sewell; Reiner Siebert; Aliyah R Sohani; Reuben Tooze; Alexandra Traverse-Glehen; Francisco Vega; Beatrice Vergier; Ashutosh D Wechalekar; Brent Wood; Luc Xerri; Wenbin Xiao
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

4.  Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma.

Authors:  Blanca Gonzalez-Farre; Joan Enric Ramis-Zaldivar; Julia Salmeron-Villalobos; Olga Balagué; Verónica Celis; Jaime Verdu-Amoros; Ferran Nadeu; Constantino Sábado; Antonio Ferrández; Marta Garrido; Federico García-Bragado; María Dolores de la Maya; José Manuel Vagace; Carlos Manuel Panizo; Itziar Astigarraga; Mara Andrés; Elaine S Jaffe; Elias Campo; Itziar Salaverria
Journal:  Haematologica       Date:  2019-02-07       Impact factor: 9.941

5.  GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner.

Authors:  Zhizhou Xia; Xiuli Zhang; Ping Liu; Ruihong Zhang; Zhangsen Huang; Donghe Li; Xinhua Xiao; Min Wu; Nannan Ning; Qianqian Zhang; Jianmin Zhang; Mingzhu Liu; Bo Jiao; Ruibao Ren
Journal:  Cell Death Dis       Date:  2021-01-09       Impact factor: 8.469

6.  Burkitt-like lymphoma with 11q aberration in a patient with AIDS and a patient without AIDS: Two cases reports and literature review.

Authors:  Jing Wang; Li Ma; Jianghong Guo; Yanfeng Xi; Enwei Xu
Journal:  Open Med (Wars)       Date:  2021-03-16

7.  Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.

Authors:  Leonie Frauenfeld; Natalia Castrejon-de-Anta; Joan Enric Ramis-Zaldivar; Sebastian Streich; Julia Salmerón-Villalobos; Franziska Otto; Annika Katharina Mayer; Julia Steinhilber; Magda Pinyol; Barbara Mankel; Colleen Ramsower; Irina Bonzheim; Falko Fend; Lisa M Rimsza; Itziar Salaverria; Elias Campo; Olga Balagué; Leticia Quintanilla-Martinez
Journal:  Blood Adv       Date:  2022-04-12

Review 8.  Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma.

Authors:  Coen J Lap; Samah Nassereddine; Kieron Dunleavy
Journal:  Curr Treat Options Oncol       Date:  2021-06-07

Review 9.  Gastrointestinal lymphoproliferative lesions: a practical diagnostic approach.

Authors:  Marco Pizzi; Elena Sabattini; Paola Parente; Alberto Bellan; Claudio Doglioni; Stefano Lazzi
Journal:  Pathologica       Date:  2020-09

Review 10.  [Burkitt-like lymphoma with 11q aberration: two cases report and literature review].

Authors:  Y Xia; Z Wang; L Wang; H R Shen; H Yin; J Z Wu; W Xu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.